Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears

Solventum Corporation (SOLV) Fell as Its HCIT Unit Hurt by AI Disruption Fears Soumya Eswaran Thu, June 4, 2026 at 8:17 PM GMT+7 3 min read SOLV ^RUT Cambiar SMID Fund, managed by Cambiar Investors, published its Q1 2026 investor letter. A copy of the letter is available to download here. The investor class (CAMMX) returned 2.21%, and the institutional class (CAMUX) returned 2.27%, underperforming the Russell 2500 Value Index s 4.77%. This shortfall was mainly due to declines in certain healthcare and industrial positions and lower exposure to the top-performing Energy sector. The broader US equity market saw mixed results, with the S&P Index down 4.3% and the Russell 2000 up 0.9%. Economic headwinds included Mag 7 stocks’ high capex budgets, AI disruption fears, and redemption gates in private credit, exacerbated by the conflict in Iran, leading to a widespread drop in stock prices. Notably, value stocks outperformed growth stocks in the quarter, offering some downside protection. In addition, please check the Fund’s top five holdings to know its best picks in 2026.

In its first-quarter 2026 investor letter, Cambiar SMID Fund highlighted stocks like Solventum Corporation (NYSE:SOLV). Solventum Corporation (NYSE:SOLV) is a healthcare company that operates through Medsurg, Dental Solutions, and Health Information Systems segments. On June 3, 2026, Solventum Corporation (NYSE:SOLV) closed at $78.36 per share. One-month return of Solventum Corporation (NYSE:SOLV) was 9.36%, and its shares gained 3.97% over the past 52 weeks. Solventum Corporation (NYSE:SOLV) has a market capitalization of $13.57 billion.

Cambiar SMID Fund stated the following regarding Solventum Corporation (NYSE:SOLV) in its Q1 2026 investor letter: